Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year

eqs_en 
0 0 01.09.22
DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
 

DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Raising forecast for the current fiscal year

01-Sep-2022 / 17:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Bremen, September 1, 2022 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development:

  • For fiscal year 2021/2022 (October 1, 2021 to September 30, 2022), revenues are now expected to increase significantly to € 17.5 million to € 18.0 million (previous forecast for fiscal year 2021/2022: stable revenues of € 16.0 million to € 16.5 million).
  • For EBIT (earnings before interest and taxes), the forecast for fiscal year 2021/2022 (October 1, 2021 to September 30, 2022) is now expected to increase significantly to € 6.0 million to € 6.5 million (previous forecast for fiscal year 2021/2022: stable EBIT of € 4.0 million to € 4.5 million).

Reasons for the increased revenues are the positive business development with the customer Hologic both in the license and in the maintenance business and, in addition, the development services with various medical technology companies have also developed very positively.

 

Contact:

Kirchhoff, Marcus / CEO

01-Sep-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: [email protected]
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1433695

 
End of Announcement DGAP News Service

1433695  01-Sep-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1433695&application_name=news&site_id=sharewise

Mevis Medical Sol.na Stock

€25.20
0.800%
The Mevis Medical Sol.na stock is trending slightly upwards today, with an increase of €0.20 (0.800%) compared to yesterday's price.

Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!